22nd Century Group Announces South Korea as First VLN® International Market
BUFFALO, N.Y., Feb. 28 (Korea Bizwire) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced the $1.6 billion1 South Korean tobacco market will be the first international market to commence sales of its VLN® reduced nicotine [...]